查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1993166

互聯醫療市場：按組件、連接技術、部署模式、應用和最終用戶分類－2026-2032年全球市場預測

Connected Healthcare Market by Component, Connectivity Technology, Deployment Model, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，互聯醫療市場價值將達到 1,450.8 億美元，到 2026 年將成長至 1,904.7 億美元，到 2032 年將達到 9,887.9 億美元，複合年成長率為 31.54%。

主要市場統計數據
基準年 2025 1450.8億美元
預計年份：2026年 1904.7億美元
預測年份 2032 9887.9億美元
複合年成長率 (%) 31.54%

簡單實現互聯醫療，強調互通性、以病人為中心的價值以及技術、政策和臨床工作流程的協調一致。

醫療設備、軟體平台、連接技術和服務的快速整合正在重新定義醫療保健的提供、協調和體驗方式。互聯醫療保健如今涵蓋了診斷、監測、治療和穿戴式技術，並整合了分析功能和平台軟體，同時輔以諮詢、實施和持續維護服務。這些要素共同建構了端到端的護理路徑，將臨床工作流程轉變為持續、主動、數據驅動的介入措施。

在人工智慧、邊緣運算、互聯互通、監管進步以及患者在所有醫療保健環境中的賦權的推動下，一場快速的變革正在重塑醫療保健的提供方式。

互聯醫療格局正經歷一場變革，這主要得益於人工智慧、邊緣運算、高頻寬蜂巢式網路技術的進步，以及對患者賦能的日益重視。人工智慧和分析技術正從單純的情境儀錶板發展成為能夠提供處方提案的決策支援工具，使臨床醫生和護理團隊能夠更有效地確定干涉措施的優先順序並管理人群風險。同時，邊緣處理降低了延遲，並實現了更高級的設備級智慧，從而支援即時治療調整和遠端監測設備的自主運作。

評估 2025 年美國關稅對連線健診供應鏈、設備採購、籌資策略和供應商關係的累積影響。

關稅和貿易政策的變化會對整個醫療保健供應鏈產生連鎖反應，影響採購選擇、零件替代方案和供應商關係。進口醫療器材與設備關稅的增加將促使採購團隊重新評估其供應商組合，加速製造地多元化，並在可能的情況下推動近岸外包。同時，硬體組件關稅的增加將促使產品團隊評估設計方案，以減少對高成本進口組件的依賴，同時不影響臨床功能。

透過細分洞察元件、應用程式、最終用戶、連接技術和部署模型之間的交互，從而影響部署和價值交付。

詳細的細分分析揭示了不同元件、應用、最終用戶、連接技術和部署模式如何相互作用，從而形成獨特的價值創造路徑。區分硬體、服務和軟體組件至關重要。硬體分為醫療設備和儀器，醫療設備又細分為診斷、監測、治療和穿戴式裝置。服務包括諮詢、安裝和維護，而軟體則涵蓋分析和平台功能。這三個觀點明確了投資和整合工作的重點方向，以實現臨床和營運目標。

美洲、歐洲、中東和非洲以及亞太地區的區域趨勢揭示了實施模式、細微的監管差異和投資重點。

美洲、歐洲、中東和非洲以及亞太地區的區域趨勢差異顯著，每個地區都有其獨特的監管、商業性和營運方面的考量。在美洲，醫療保健系統通常優先考慮與主流電子健康記錄平台的互通性、基於價值的合約以及快速的商業化路徑，這為整合設備和軟體解決方案創造了有利環境，這些解決方案能夠提供成本和效能優勢。相較之下，歐洲和中東及非洲的管理體制和採購模式各不相同，協調工作、隱私權標準和公共部門採購規則影響部署策略。

透過對產品系列、夥伴關係、併購活動、市場推出策略和創新藍圖的分析，可以深入了解公司的策略和競爭差異化優勢。

在互聯醫療領域，企業行為日益因產品架構、夥伴關係方式和商業化模式的不同而呈現差異化趨勢。成熟的醫療設備製造商傾向於將軟體和服務整合到捆綁產品中，並著重強調臨床檢驗和報銷途徑。純軟體供應商則專注於平台擴充性、分析能力和開發者生態系統，而服務機構則透過深度整合、部署能力和長期支援合約脫穎而出。

為產業領導者提供切實可行的建議，以加快採用速度、減少障礙、簡化採購流程並調整商業策略。

產業領導者若想從互聯醫療中獲益，應優先考慮與組織優先事項相符的可操作、可衡量的措施。首先，在採購和產品設計決策階段就納入互通性和資料管治需求，進而降低後續整合成本。其次，制定能夠共用部署風險並以可衡量的臨床結果而非簡單的銷售量獎勵的商業協議。這樣就能使供應商的獎勵與醫療品質和長期價值創造保持一致。

為了確保資料的完整性和見解的質量，我們採用了穩健的調查方法，結合了初步訪談、專家檢驗、文獻整合和統計分析。

本摘要的研究採用了一種混合方法，結合了初步研究、專家檢驗以及公開資訊和專有資訊的結構化整合。透過對臨床醫生、技術領導者、採購專業人員和供應商的訪談，我們獲得了關於採用促進因素、整合挑戰和商業性趨勢的定性背景資訊。專家檢驗研討會檢驗了新的假設，並完善了組件、應用、最終用戶、連接技術和部署模型等方面的分類。

結論：整合臨床、商業和技術相關人員的見解，以指導短期優先事項和長期計畫的決策。

本文提出的策略整合凸顯了一個關鍵事實：對於致力於改善治療效果和提升營運韌性的機構而言，互聯醫療已不再是可選項。醫療設備硬體、分析軟體、服務交付和互聯互通之間的相互依存關係，要求技術、臨床和採購部門之間進行協調規劃，才能確保專案成功。那些精心整合互通性、合規性和變更管理的機構，能夠實現更快的部署速度和更顯著的臨床效益。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 互聯醫療市場：依組件分類

  • 硬體
    • 裝置
      • 診斷設備
      • 監控設備
      • 治療設備
      • 穿戴式裝置
    • 裝置
  • 服務
    • 諮詢
    • 實施與整合
    • 維護和支援
  • 軟體
    • 分析軟體
    • 平台軟體

第9章 互聯醫療市場：依互聯技術分類

  • Bluetooth
  • 細胞
    • 4G
    • 5G
  • Wi-Fi

第10章 互聯醫療市場：依部署模式分類

  • 基於雲端的
  • 混合
  • 現場

第11章 互聯醫療市場：依應用領域分類

  • 慢性病管理
  • 行動醫療
  • 遠端患者監護
  • 遠端醫療

第12章 互聯醫療保健市場：依最終用戶分類

  • 門診部
  • 居家照護
  • 醫院和診所
  • 研究機構

第13章 互聯醫療市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 互聯醫療市場：依群體分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 互聯醫療市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國互聯醫療市場

第17章：中國的互聯醫療市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Allscripts Healthcare Solutions, Inc.
  • AMD Global Telemedicine, Inc.
  • Amwell（American Well Corporation）
  • Biofourmis, Inc.
  • Boston Scientific Corporation
  • CareSimple, Inc.
  • Cerner Corporation
  • Cisco Systems, Inc.
  • Current Health, Inc.
  • Epic Systems Corporation
  • GE HealthCare Technologies Inc.
  • HealthSnap, Inc.
  • IBM Corporation
  • iHealth Labs, Inc.
  • Koninklijke Philips NV
  • Life Image, Inc.
  • Medtronic plc
  • Mindray Medical International Limited
  • Nihon Kohden Corporation
  • Optum, Inc.（part of UnitedHealth Group）
  • Oracle Corporation
  • ResMed Inc.
  • Siemens Healthineers AG
  • Teladoc Health, Inc.
  • Tunstall Healthcare（Tunstall Group）
  • TytoCare, Inc.
  • Vivify Health, Inc.
Product Code: MRR-1A1A064C02FB

The Connected Healthcare Market was valued at USD 145.08 billion in 2025 and is projected to grow to USD 190.47 billion in 2026, with a CAGR of 31.54%, reaching USD 988.79 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 145.08 billion
Estimated Year [2026] USD 190.47 billion
Forecast Year [2032] USD 988.79 billion
CAGR (%) 31.54%

A concise introduction to connected healthcare emphasizing interoperability, patient-centric value, and alignment of technology, policy and clinical workflows

The rapid convergence of medical devices, software platforms, connectivity and services is redefining how care is delivered, coordinated and experienced. Connected healthcare now spans diagnostic, monitoring, therapeutic and wearable technologies integrated with analytics and platform software, supported by consulting, installation, and ongoing maintenance services. Together, these elements create end-to-end care pathways that shift clinical workflows toward continuous, proactive, and data-driven interventions.

Across ambulatory centers, hospitals, home care and research settings, adoption is being shaped by regulatory expectations, reimbursement evolution, and patient demand for convenience and personalization. Connectivity options from Bluetooth to cellular and Wi-Fi, coupled with flexible deployment models such as cloud, hybrid and on-premises architectures, enable a wide array of deployment choices that must be weighed against security, latency and integration requirements. As clinical teams and technology leaders pursue interoperability and user-centric design, they confront tradeoffs between rapid feature delivery and long-term maintainability.

This introduction frames the executive imperative: translate technical capability into measurable clinical and operational value. By focusing on interoperability, data governance and change management, organizations can accelerate adoption while protecting care quality and patient privacy. The remainder of this summary distills the most consequential shifts, segmentation insights, regional dynamics and recommended actions for leadership.

Rapid transformative shifts reshaping healthcare delivery driven by AI, edge computing, connectivity, regulatory evolution and patient empowerment across settings

The landscape for connected healthcare is undergoing transformative shifts driven by advances in artificial intelligence, edge computing, higher-bandwidth cellular networks and an intensified focus on patient empowerment. AI and analytics are moving from descriptive dashboards to prescriptive decision support, enabling clinicians and care teams to prioritize interventions and manage population risks more effectively. Meanwhile, edge processing is reducing latency and enabling richer device-level intelligence that supports real-time therapeutic adjustments and autonomy for remote monitoring devices.

Concurrently, regulatory frameworks are catching up with digital health realities, with authorities emphasizing safety, data portability and explainability. This regulatory evolution compels vendors and health systems to embed compliance and validation practices throughout product lifecycles. Meanwhile, commercial models are shifting away from single-device sales toward outcomes-oriented contracts and subscription services, generating new demands for robust measurement and evidence generation.

Taken together, these shifts are dissolving traditional boundaries between devices, software and services. As interoperability and user experience become the principal differentiators, leaders must recalibrate procurement, clinical pathways and partnership strategies to capture the clinical and operational benefits attainable in a connected, data-driven environment.

Evaluating the cumulative impact of United States tariffs in 2025 on connected healthcare supply chains, device sourcing, procurement strategies and vendor relationships

The imposition of tariffs and trade policy changes can reverberate across connected healthcare supply chains, influencing sourcing choices, component substitution and vendor relationships. Increased duty burdens on imported devices and equipment drive procurement teams to reassess supplier portfolios, accelerating diversification of manufacturing bases and encouraging near-shoring where feasible. In parallel, tariffs on hardware components prompt product teams to evaluate design alternatives that reduce dependence on higher-cost imported parts without compromising clinical functionality.

Beyond direct cost effects, tariffs influence commercial negotiations and contractual structures. Buyers and vendors may renegotiate terms to allocate tariff risk, adjust lead times, or restructure support and maintenance arrangements to limit exposure. These dynamics also affect innovation pipelines: development programs that rely on specific overseas components can face delays, prompting companies to prioritize modular architectures and software-centric upgrades that are less susceptible to border tax fluctuations.

Strategically, organizations should treat tariff changes as a catalyst to strengthen supply chain resilience, clarify total cost of ownership considerations, and expand vendor risk assessment to include trade policy scenarios. By integrating procurement, engineering and clinical stakeholders, decision makers can mitigate disruption while preserving clinical performance and continuity of care delivery.

Segmentation insights on component, application, end user, connectivity technology, and deployment model interactions shaping adoption and value delivery

A nuanced segmentation view reveals how different components, applications, end users, connectivity technologies and deployment models interact to create distinct value pathways. Component distinctions between hardware, services and software are fundamental: hardware divides into devices and equipment where devices further separate into diagnostic, monitoring, therapeutic and wearable categories, while services encompass consulting, installation and maintenance and software spans analytics and platform capabilities. This tripartite lens clarifies where investment and integration effort must be focused to achieve clinical and operational goals.

Application segmentation exposes differing adoption rhythms; chronic disease management, mobile health, remote patient monitoring and telehealth each demand tailored workflows and evidence. End-user contexts drive implementation complexity: ambulatory centers and hospitals require tight EHR and clinical workflow integration, home care emphasizes usability and minimal onboarding friction, and research institutes prioritize data fidelity and extensibility. Connectivity choices from Bluetooth to cellular and Wi-Fi, with cellular subdivided between fourth-generation and fifth-generation networks, influence latency, throughput and roaming behavior, shaping device design and platform expectations.

Finally, deployment models matter: cloud-based solutions accelerate scalability and analytics, hybrid approaches balance latency and control, while on-premises options support stringent data locality and security requirements. Decision makers should map targeted applications and end-user needs to component capabilities, connectivity tradeoffs and deployment models to craft pragmatic roadmaps that balance speed, cost and compliance.

Regional dynamics across the Americas, Europe, Middle East & Africa, and Asia-Pacific that reveal adoption patterns, regulatory nuance and investment focus

Regional dynamics vary meaningfully across the Americas, Europe, Middle East & Africa, and Asia-Pacific, each presenting distinct regulatory, commercial and operational considerations. In the Americas, health systems often prioritize interoperability with major electronic health record platforms, value-based contracting and rapid commercialization paths, creating fertile ground for integrated device-software solutions that demonstrate cost and outcome benefits. By contrast, Europe, the Middle East & Africa exhibit heterogenous regulatory regimes and procurement models, where harmonization efforts, privacy standards and public-sector purchasing rules shape deployment strategies.

Asia-Pacific demonstrates a mix of high-velocity technology adoption in urban centers alongside diverse infrastructure realities in emerging markets, driving demand for adaptable connectivity options and flexible deployment models. Investors and product teams must calibrate go-to-market approaches to these regional realities, aligning evidence generation, localization and partnerships to local reimbursement and regulatory environments. Cross-regional partnerships and localized service capabilities frequently determine the speed and scale of adoption.

Leaders should therefore approach regional planning as a portfolio exercise, identifying where centralized strategies can be leveraged and where market-specific adaptations are required to secure clinical acceptance and sustainable commercial traction.

Insights into company strategies and competitive differentiation that examine product portfolios, partnerships, M&A activity, go-to-market and innovation roadmaps

Company behavior in connected healthcare increasingly differentiates along product architecture, partnership approach and commercialization models. Established medical device manufacturers tend to integrate software and services into bundled offerings, emphasizing clinical validation and reimbursement pathways. Pure-play software providers focus on platform extensibility, analytics and developer ecosystems, while service organizations differentiate through deep integration, implementation capacity and long-cycle support agreements.

Partnerships and alliances are central to competitive positioning. Strategic collaborations between device makers, software platforms and connectivity providers accelerate time to market and reduce integration risk. Mergers and acquisitions are frequently targeted to close capability gaps-particularly where analytics, regulatory expertise or scale in deployment services are required. At the same time, innovation leaders invest in modular product design, API-first architectures and rigorous real-world evidence generation to support outcomes-based commercial models.

For buyers, evaluating vendors requires attention to roadmaps, interoperability commitments, validation data and post-sales support. For vendors, the imperative is to demonstrate measurable clinical and operational impact, align commercial incentives with customer success, and maintain flexible delivery models to meet a wide range of deployment and regulatory requirements.

Actionable recommendations empowering industry leaders to accelerate adoption, reduce friction, streamline procurement and align commercial strategy

Industry leaders seeking to capture the benefits of connected healthcare should prioritize actions that are practical, measurable and aligned with institutional priorities. First, embed interoperability and data governance requirements into procurement and product design decisions up front to reduce later integration costs. Second, structure commercial agreements to share implementation risk and incentivize measurable clinical outcomes rather than simple unit sales. This realigns vendor incentives with care quality and long-term value creation.

Third, invest in supply chain resilience by diversifying sourcing, validating alternate components and adopting modular hardware and software designs that are less sensitive to single-source disruptions. Fourth, cultivate internal capabilities in change management and digital workflow redesign so that clinical teams can absorb new modalities without productivity loss. Fifth, adopt a phased rollout strategy that pairs early clinical champions with robust measurement plans to demonstrate value and guide scale-up.

Taken together, these recommendations help organizations reduce adoption friction, retain clinical integrity, and accelerate the transition from pilot projects to durable, scaled programs that deliver improved outcomes and operational efficiencies.

Robust methodology blending primary interviews, expert validation, literature synthesis and statistical analysis to ensure data integrity and insight quality

The research underpinning this summary employs a mixed methodology combining primary engagements, expert validation and structured synthesis of public and proprietary sources. Primary interviews with clinicians, technology leaders, procurement specialists and vendors provided qualitative context on adoption drivers, integration challenges and commercial dynamics. Expert validation workshops were used to stress-test emerging hypotheses and refine categorizations across components, applications, end users, connectivity technologies and deployment models.

Secondary research included targeted review of regulatory guidance, technical standards and clinical literature to establish the evidentiary baseline for clinical and technical assertions. Where quantitative techniques were applied, statistical analysis and triangulation methods were used to ensure robustness and repeatability of findings. The methodology emphasized transparency in assumptions, reproducibility of analytical steps and clear linkage between evidence and recommendations.

This approach supports confident decision making by combining frontline practitioner insight with systematic analysis, enabling executives to translate findings into prioritized actions that account for both technical feasibility and clinical imperatives.

Conclusion synthesizing implications for clinical, commercial and technical stakeholders to guide near-term priorities and long-term program decisions

The strategic synthesis presented here underscores a central truth: connected healthcare is no longer optional for organizations that seek to improve outcomes and operational resilience. The interdependence of device hardware, analytics software, service delivery and connectivity means that successful programs require coordinated planning across technology, clinical and procurement functions. Where organizations thoughtfully integrate interoperability, regulatory readiness and change management, they realize faster adoption and stronger clinical benefit.

Regional nuance, tariff exposure and vendor strategies will continue to shape implementation choices, but these variables do not obviate the need for clear, measurable objectives. Instead, they demand a portfolio approach to market entry, risk management and partnership selection. By applying the segmentation insights and recommended actions in this summary, leaders can prioritize initiatives that deliver near-term clinical value while building the infrastructure and capabilities required for long-term transformation.

In closing, the pathway to success is pragmatic: align technology selection with workflow redesign, secure executive sponsorship, and insist on evidence that links digital interventions to meaningful clinical and economic outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Connected Healthcare Market, by Component

  • 8.1. Hardware
    • 8.1.1. Device
      • 8.1.1.1. Diagnostic Devices
      • 8.1.1.2. Monitoring Devices
      • 8.1.1.3. Therapeutic Devices
      • 8.1.1.4. Wearable Devices
    • 8.1.2. Equipment
  • 8.2. Services
    • 8.2.1. Consulting
    • 8.2.2. Installation And Integration
    • 8.2.3. Maintenance And Support
  • 8.3. Software
    • 8.3.1. Analytics Software
    • 8.3.2. Platform Software

9. Connected Healthcare Market, by Connectivity Technology

  • 9.1. Bluetooth
  • 9.2. Cellular
    • 9.2.1. 4G
    • 9.2.2. 5G
  • 9.3. Wi Fi

10. Connected Healthcare Market, by Deployment Model

  • 10.1. Cloud Based
  • 10.2. Hybrid
  • 10.3. On Premises

11. Connected Healthcare Market, by Application

  • 11.1. Chronic Disease Management
  • 11.2. Mobile Health
  • 11.3. Remote Patient Monitoring
  • 11.4. Telehealth

12. Connected Healthcare Market, by End User

  • 12.1. Ambulatory Centers
  • 12.2. Home Care
  • 12.3. Hospitals And Clinics
  • 12.4. Research Institutes

13. Connected Healthcare Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Connected Healthcare Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Connected Healthcare Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Connected Healthcare Market

17. China Connected Healthcare Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Allscripts Healthcare Solutions, Inc.
  • 18.6. AMD Global Telemedicine, Inc.
  • 18.7. Amwell (American Well Corporation)
  • 18.8. Biofourmis, Inc.
  • 18.9. Boston Scientific Corporation
  • 18.10. CareSimple, Inc.
  • 18.11. Cerner Corporation
  • 18.12. Cisco Systems, Inc.
  • 18.13. Current Health, Inc.
  • 18.14. Epic Systems Corporation
  • 18.15. GE HealthCare Technologies Inc.
  • 18.16. HealthSnap, Inc.
  • 18.17. IBM Corporation
  • 18.18. iHealth Labs, Inc.
  • 18.19. Koninklijke Philips N.V.
  • 18.20. Life Image, Inc.
  • 18.21. Medtronic plc
  • 18.22. Mindray Medical International Limited
  • 18.23. Nihon Kohden Corporation
  • 18.24. Optum, Inc. (part of UnitedHealth Group)
  • 18.25. Oracle Corporation
  • 18.26. ResMed Inc.
  • 18.27. Siemens Healthineers AG
  • 18.28. Teladoc Health, Inc.
  • 18.29. Tunstall Healthcare (Tunstall Group)
  • 18.30. TytoCare, Inc.
  • 18.31. Vivify Health, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CONNECTED HEALTHCARE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CONNECTED HEALTHCARE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES CONNECTED HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA CONNECTED HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY HARDWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY DEVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY DEVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY DIAGNOSTIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY DIAGNOSTIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY MONITORING DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY MONITORING DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY MONITORING DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY THERAPEUTIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY THERAPEUTIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY THERAPEUTIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY WEARABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY WEARABLE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY WEARABLE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY CONSULTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY CONSULTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY CONSULTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY INSTALLATION AND INTEGRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY INSTALLATION AND INTEGRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY INSTALLATION AND INTEGRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY MAINTENANCE AND SUPPORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY MAINTENANCE AND SUPPORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY MAINTENANCE AND SUPPORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY ANALYTICS SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY ANALYTICS SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY ANALYTICS SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY PLATFORM SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY PLATFORM SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY PLATFORM SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY BLUETOOTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY BLUETOOTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY BLUETOOTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY CELLULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY CELLULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY CELLULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY CELLULAR, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY 4G, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY 4G, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY 4G, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY 5G, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY 5G, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY 5G, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY WI FI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY WI FI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY WI FI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY CLOUD BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY CLOUD BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY CLOUD BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY HYBRID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY HYBRID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY HYBRID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY ON PREMISES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY ON PREMISES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY ON PREMISES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY MOBILE HEALTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY MOBILE HEALTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY MOBILE HEALTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY REMOTE PATIENT MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY REMOTE PATIENT MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY REMOTE PATIENT MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY TELEHEALTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY TELEHEALTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY TELEHEALTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY AMBULATORY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY AMBULATORY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY AMBULATORY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS CONNECTED HEALTHCARE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS CONNECTED HEALTHCARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS CONNECTED HEALTHCARE MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS CONNECTED HEALTHCARE MARKET SIZE, BY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS CONNECTED HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS CONNECTED HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS CONNECTED HEALTHCARE MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS CONNECTED HEALTHCARE MARKET SIZE, BY CELLULAR, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS CONNECTED HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS CONNECTED HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS CONNECTED HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA CONNECTED HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA CONNECTED HEALTHCARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA CONNECTED HEALTHCARE MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA CONNECTED HEALTHCARE MARKET SIZE, BY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA CONNECTED HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA CONNECTED HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA CONNECTED HEALTHCARE MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA CONNECTED HEALTHCARE MARKET SIZE, BY CELLULAR, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA CONNECTED HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA CONNECTED HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA CONNECTED HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA CONNECTED HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA CONNECTED HEALTHCARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA CONNECTED HEALTHCARE MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA CONNECTED HEALTHCARE MARKET SIZE, BY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA CONNECTED HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA CONNECTED HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA CONNECTED HEALTHCARE MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA CONNECTED HEALTHCARE MARKET SIZE, BY CELLULAR, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA CONNECTED HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA CONNECTED HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA CONNECTED HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA CONNECTED HEALTHCARE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA CONNECTED HEALTHCARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA CONNECTED HEALTHCARE MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA CONNECTED HEALTHCARE MARKET SIZE, BY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA CONNECTED HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA CONNECTED HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA CONNECTED HEALTHCARE MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA CONNECTED HEALTHCARE MARKET SIZE, BY CELLULAR, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA CONNECTED HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA CONNECTED HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA CONNECTED HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE CONNECTED HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE CONNECTED HEALTHCARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE CONNECTED HEALTHCARE MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE CONNECTED HEALTHCARE MARKET SIZE, BY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE CONNECTED HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE CONNECTED HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE CONNECTED HEALTHCARE MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE CONNECTED HEALTHCARE MARKET SIZE, BY CELLULAR, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE CONNECTED HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE CONNECTED HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE CONNECTED HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST CONNECTED HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST CONNECTED HEALTHCARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST CONNECTED HEALTHCARE MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST CONNECTED HEALTHCARE MARKET SIZE, BY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST CONNECTED HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST CONNECTED HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST CONNECTED HEALTHCARE MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST CONNECTED HEALTHCARE MARKET SIZE, BY CELLULAR, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST CONNECTED HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST CONNECTED HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST CONNECTED HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA CONNECTED HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA CONNECTED HEALTHCARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA CONNECTED HEALTHCARE MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA CONNECTED HEALTHCARE MARKET SIZE, BY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA CONNECTED HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA CONNECTED HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA CONNECTED HEALTHCARE MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA CONNECTED HEALTHCARE MARKET SIZE, BY CELLULAR, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA CONNECTED HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA CONNECTED HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA CONNECTED HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC CONNECTED HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC CONNECTED HEALTHCARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC CONNECTED HEALTHCARE MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC CONNECTED HEALTHCARE MARKET SIZE, BY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC CONNECTED HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC CONNECTED HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC CONNECTED HEALTHCARE MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC CONNECTED HEALTHCARE MARKET SIZE, BY CELLULAR, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC CONNECTED HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC CONNECTED HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC CONNECTED HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN CONNECTED HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN CONNECTED HEALTHCARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN CONNECTED HEALTHCARE MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN CONNECTED HEALTHCARE MARKET SIZE, BY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN CONNECTED HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN CONNECTED HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN CONNECTED HEALTHCARE MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN CONNECTED HEALTHCARE MARKET SIZE, BY CELLULAR, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN CONNECTED HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN CONNECTED HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN CONNECTED HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 203. GCC CONNECTED HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 204. GCC CONNECTED HEALTHCARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 205. GCC CONNECTED HEALTHCARE MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 206. GCC CONNECTED HEALTHCARE MARKET SIZE, BY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 207. GCC CONNECTED HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 208. GCC CONNECTED HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 209. GCC CONNECTED HEALTHCARE MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 210. GCC CONNECTED HEALTHCARE MARKET SIZE, BY CELLULAR, 2018-2032 (USD MILLION)
  • TABLE 211. GCC CONNECTED HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 212. GCC CONNECTED HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 213. GCC CONNECTED HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION CONNECTED HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION CONNECTED HEALTHCARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION CONNECTED HEALTHCARE MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION CONNECTED HEALTHCARE MARKET SIZE, BY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION CONNECTED HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION CONNECTED HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION CONNECTED HEALTHCARE MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION CONNECTED HEALTHCARE MARKET SIZE, BY CELLULAR, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION CONNECTED HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION CONNECTED HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION CONNECTED HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS CONNECTED HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS CONNECTED HEALTHCARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 227. BRICS CONNECTED HEALTHCARE MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS CONNECTED HEALTHCARE MARKET SIZE, BY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS CONNECTED HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS CONNECTED HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS CONNECTED HEALTHCARE MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS CONNECTED HEALTHCARE MARKET SIZE, BY CELLULAR, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS CONNECTED HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS CONNECTED HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS CONNECTED HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 236. G7 CONNECTED HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 237. G7 CONNECTED HEALTHCARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 238. G7 CONNECTED HEALTHCARE MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 239. G7 CONNECTED HEALTHCARE MARKET SIZE, BY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 240. G7 CONNECTED HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 241. G7 CONNECTED HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 242. G7 CONNECTED HEALTHCARE MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 243. G7 CONNECTED HEALTHCARE MARKET SIZE, BY CELLULAR, 2018-2032 (USD MILLION)
  • TABLE 244. G7 CONNECTED HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 245. G7 CONNECTED HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 246. G7 CONNECTED HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 247. NATO CONNECTED HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 248. NATO CONNECTED HEALTHCARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 249. NATO CONNECTED HEALTHCARE MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 250. NATO CONNECTED HEALTHCARE MARKET SIZE, BY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 251. NATO CONNECTED HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 252. NATO CONNECTED HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 253. NATO CONNECTED HEALTHCARE MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 254. NATO CONNECTED HEALTHCARE MARKET SIZE, BY CELLULAR, 2018-2032 (USD MILLION)
  • TABLE 255. NATO CONNECTED HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 256. NATO CONNECTED HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 257. NATO CONNECTED HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 258. GLOBAL CONNECTED HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES CONNECTED HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES CONNECTED HEALTHCARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED STATES CONNECTED HEALTHCARE MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES CONNECTED HEALTHCARE MARKET SIZE, BY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES CONNECTED HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES CONNECTED HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES CONNECTED HEALTHCARE MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES CONNECTED HEALTHCARE MARKET SIZE, BY CELLULAR, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED STATES CONNECTED HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES CONNECTED HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES CONNECTED HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 270. CHINA CONNECTED HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 271. CHINA CONNECTED HEALTHCARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 272. CHINA CONNECTED HEALTHCARE MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 273. CHINA CONNECTED HEALTHCARE MARKET SIZE, BY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 274. CHINA CONNECTED HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 275. CHINA CONNECTED HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 276. CHINA CONNECTED HEALTHCARE MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 277. CHINA CONNECTED HEALTHCARE MARKET SIZE, BY CELLULAR, 2018-2032 (USD MILLION)
  • TABLE 278. CHINA CONNECTED HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 279. CHINA CONNECTED HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 280. CHINA CONNECTED HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)